IFNA1 and heart failure: Since LTD modulates the innate and adaptive immune system through IFN-like functions in addition to its antiviral potential [45,46,47], we analyzed whether this drug may have an impact on the clinical outcome of patients with active B19V infection and persisting symptomatic heart failure during this present study, independently of baseline LVEF (Figure 1).